What's new

Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised

Feb 26, 2025 - 13:45
 0
Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Sunlenca, lenacapavir, Date of authorisation: 17/08/2022, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Auto Trader expands Co-Driver with two new AI powered vehicle advert tools

Next Article

Human medicines European public assessment report (EPAR): Sitagliptin SUN, sitag...

Related Posts

Human medicines European public assessment report (EPAR): Emblaveo, aztreonam,avibactam, Date of authorisation: 22/04/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 12, 2025  0

EMEA-003499-PIP01-23

EMEA-003499-PIP01-23

Feb 13, 2025  0

Quick guide: How to search, view and download a Clinica...

Feb 18, 2025  0